ClinicalTrials.govpublic full text
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
endometrial cancer, stage iii with residual disease, stage iv, recurrent endometrial cancer after adjuvant therapy only, ctdna testing, 25-337, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 827874
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.